Detalhe da pesquisa
1.
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study.
Cancer Immunol Immunother
; 73(6): 106, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38634928
2.
Use of concomitant proton pump inhibitors, statins or metformin in patients treated with pembrolizumab for metastatic urothelial carcinoma: data from the ARON-2 retrospective study.
Cancer Immunol Immunother
; 72(11): 3665-3682, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37676282
3.
The prognostic significance of lactate dehydrogenase levels in seminoma patients with advanced disease: an analysis by the Global Germ Cell Tumor Collaborative Group (G3).
World J Urol
; 39(9): 3407-3414, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33683412
4.
The Role of Obesity in Renal Cell Carcinoma Patients: Clinical-Pathological Implications.
Int J Mol Sci
; 20(22)2019 Nov 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31766196
5.
Prognostic role of the cumulative toxicity in patients affected by metastatic renal cells carcinoma and treated with first-line tyrosine kinase inhibitors.
Anticancer Drugs
; 28(2): 206-212, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27754995
6.
Serum HER2 extracellular domain levels and HER2 circulating tumor cell status in patients with metastatic breast cancer.
Future Oncol
; 12(17): 2001-8, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27255717
7.
Estramustine phosphate sodium in heavily pretreated patients with metastatic breast cancer: a retrospective consecutive case series.
Int J Clin Oncol
; 20(1): 90-4, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24722887
8.
CT-guided bone biopsy in cancer patients with suspected bone metastases: retrospective review of 308 procedures.
Radiol Med
; 119(11): 852-60, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24700152
9.
Evolving paradigms in breast cancer screening: Balancing efficacy, personalization, and equity.
Eur J Radiol
; 172: 111321, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38244317
10.
Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?
Eur Urol Oncol
; 7(1): 102-111, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37481365
11.
Role of breast surgery in T1-3 breast cancer patients with synchronous bone metastases.
Breast Cancer Res Treat
; 138(1): 303-10, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23412771
12.
Discordant hormone receptor and human epidermal growth factor receptor 2 status in bone metastases compared to primary breast cancer.
Acta Oncol
; 52(8): 1649-56, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23327413
13.
Chemoprevention and Lifestyle Modifications for Risk Reduction in Sporadic and Hereditary Breast Cancer.
Healthcare (Basel)
; 11(16)2023 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37628558
14.
Image-Guided Ablations in Patients with Recurrent Renal Cell Carcinoma.
J Clin Med
; 12(15)2023 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37568303
15.
Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1).
Clin Genitourin Cancer
; 21(5): e309-e319.e1, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37062658
16.
Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study.
Target Oncol
; 18(4): 559-570, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37369815
17.
Geographical differences in the management of metastatic de novo renal cell carcinoma in the era of immune-combinations.
Minerva Urol Nephrol
; 75(4): 460-470, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37530662
18.
Oral metronomic cyclophosphamide and methotrexate plus fulvestrant in advanced breast cancer patients: a mono-institutional case-cohort report.
Breast J
; 18(5): 470-4, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22827581
19.
Emerging treatment landscape of non-muscle invasive bladder cancer.
Expert Opin Biol Ther
; 22(6): 717-734, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35634893
20.
Statins and renal cell carcinoma: Antitumor activity and influence on cancer risk and survival.
Crit Rev Oncol Hematol
; 176: 103731, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35718065